Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications
Open Access
- 25 April 2025
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Abstract
Testicular microcalcifications consist of hydroxyapatite and have been associated with an increased risk of testicular germ cell tumors (TGCTs) but are also found in benign cases such as loss-of-function variants in the phosphate transporter SLC34A2. Here, we show that fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, is expressed in testicular germ cell neoplasia in situ (GCNIS), embryonal carcinoma (EC), and human embryonic stem cells. FGF23 is not glycosylated in TGCTs and therefore cleaved into a C-terminal fragment which competitively antagonizes full-length FGF23. Here, Fgf23 knockout mice presented with marked calcifications in the epididymis, spermatogenic arrest, and focally germ cells expressing the osteoblast marker Osteocalcin (gene name: Bglap, protein name). Moreover, the frequent testicular microcalcifications in mice with no functional androgen receptor and lack of circulating gonadotropins are associated with lower Slc34a2 and higher Bglap/Slc34a1 (protein name: NPT2a) expression compared with wild-type mice. In accordance, human testicular specimens with microcalcifications also have lower SLC34A2 and a subpopulation of germ cells express phosphate transporter NPT2a, Osteocalcin, and RUNX2 highlighting aberrant local phosphate handling and expression of bone-specific proteins. Mineral disturbance in vitro using calcium or phosphate treatment induced deposition of calcium phosphate in a spermatogonial cell line and this effect was fully rescued by the mineralization inhibitor pyrophosphate. In conclusion, testicular microcalcifications arise secondary to local alterations in mineral homeostasis, which in combination with impaired Sertoli cell function and reduced levels of mineralization inhibitors due to high alkaline phosphatase activity in GCNIS and TGCTs facilitate osteogenic-like differentiation of testicular cells and deposition of hydroxyapatite.Keywords
All Related Versions
Funding Information
- Danish Cancer Society Research Center
- Independent Research Fund Denmark
- Novo Nordisk Fonden
- Aase og Ejnar Danielsens Fond
- Hørslev-Fonden
- Dagmar Wilhelms Fund
- Ib Henriksens Fund
This publication has 62 references indexed in Scilit:
- Increased Osteopontin Contributes to Inhibition of Bone Mineralization in FGF23-Deficient MiceJournal of Bone and Mineral Research, 2013
- Evidence for FGF23 Involvement in a Bone-Kidney Axis Regulating Bone Mineralization and Systemic Phosphate and Vitamin D Homeostasis2012
- Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adultsCancer, 2010
- Expression of Runx2 transcription factor in non‐skeletal tissues, sperm and brainJournal of Cellular Physiology, 2008
- Amelioration of the premature ageing‐like features of Fgf‐23 knockout mice by genetically restoring the systemic actions of FGF‐23The Journal of Pathology, 2008
- Two novel GALNT3 mutations in familial tumoral calcinosisAmerican Journal of Medical Genetics Part A, 2007
- Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiationVirchows Archiv, 2007
- The pluripotency homeobox gene NANOG is expressed in human germ cell tumorsCancer, 2005
- The Effect of Estrogen Administration In Vivo on the Elemental Composition of the Intraluminal Fluids of the Seminiferous Tubules, Rete Testis, and Epididymis of the RatJournal of Andrology, 1983
- Cell‐surface antigens of a clonal human embryonal carcinoma cell line: Morphological and antigenic differentiation in cultureInternational Journal of Cancer, 1982